Table 2.
Threshold Value | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | False Positives (n) | False Negatives (n) | Test Positives (n) |
---|---|---|---|---|---|---|---|
uβ2m | |||||||
≥0.5 μg/min | 80 | 67 | 68 | 79 | 23 | 12 | 71 |
≥1.0 μg/min | 73 | 75 | 72 | 76 | 17 | 16 | 61 |
≥1.5 μg/min | 65 | 83 | 76 | 73 | 12 | 21 | 51 |
≥2.0 μg/min | 58 | 83 | 76 | 70 | 12 | 24 | 47 |
≥2.5 μg/min | 55 | 84 | 75 | 68 | 11 | 27 | 44 |
uα1m | |||||||
≥40 μg/min | 77 | 71 | 70 | 78 | 20 | 14 | 66 |
≥50 μg/min | 65 | 83 | 76 | 73 | 12 | 21 | 51 |
≥60 μg/min | 57 | 86 | 77 | 69 | 10 | 26 | 44 |
≥70 μg/min | 45 | 88 | 77 | 65 | 8 | 33 | 35 |
≥80 μg/min | 42 | 90 | 78 | 64 | 11 | 27 | 44 |
iMN, idiopathic membranous nephropathy; PPV, positive predictive value; NPV, negative predictive value; uβ2m, urinary β2-microglobulin; uα1m, urinary α1-microglobulin. Test positives are the number of patients with a urinary α1- and β2-microglobulin excretion greater than the threshold value.